Rekha Sathyanarayana
About Rekha Sathyanarayana
Title and Role
Rekha Sathyanarayana holds the position of Senior Vice President of Clinical Operations. In this role, she leverages over 25 years of experience in pharmaceutical development, managing diverse therapeutic projects and leading clinical operations with strategic oversight.
Clinical Operations Leadership Experience
Rekha Sathyanarayana has accumulated over 15 years in key leadership roles within Clinical Operations. Notably, she has served as Vice President of Clinical Operations at Titan Pharmaceuticals, managing significant programs in Parkinson’s Disease and Opioid addiction. During her tenure, she successfully secured a NIDA grant, showcasing her ability to lead high-stakes projects.
Achievements in Pharmaceutical Development
Rekha has successfully overseen global pivotal trials at pharmaceutical companies, contract research organizations (CROs), and biotech firms, culminating in the market introduction of six commercial products. Her efforts were instrumental in securing NDA approvals for three products at Depomed Inc. Additionally, she led her department through Investigational New Drug (IND) and Biologics License Application (BLA) enabling programs at Revance Therapeutics.
Education and Certifications
Rekha earned a BS in Microbiology from Bangalore University and an advanced BS in Medical Technology from Northern Illinois University. Enhancing her academic background, she attained an Executive Leadership Management certification from Stanford University Graduate School of Business.
Previous Positions and Responsibilities
Throughout her career, Rekha has held increasing responsibilities at various organizations including Neopath Inc, R2 Technologies, PPD Inc, and Abbott Labs. Her leadership has played a critical role in achieving 510K and NDA approvals, demonstrating her impact on regulatory success and product development.